PGK1 and Parkinson disease: Enhanced PGK1 activity mitigates the loss of dopaminergic neurons, reduces PD-related symptoms, and slows disease progression in genetic-, chemical models of PD, and in induced pluripotent stem cells (iPSCs), highlighting the benefits of increased glycolysis in PD [43].